This study was designed to investigate whether anti-IgE-induced or ionophore A23187-induced histamine release from human basophils is regulated by exogenous nitric oxide (NO), and to assess some similarities between the effect of NO on basophils and that on rat peritoneal mast cells (RPMC). The NO donor, sodium nitroprusside (SNP), inhibited A23187-induced histamine release from crude human basophils and crude RPMC in a dose-dependent fashion. This downregulation was still observed when SNP was washed out just before the cell stimulation, indicating that the effect of SNP was irreversible. The downregulation disappeared in both purified cell populations after the removal of contaminating cells. However, when purified cells were preincubated with SNP in the presence of 5 mM N-acetylcysteine (NAC), increasing the bioavailability of NO, the downregulation was recovered. The presence of NAC significantly augmented the downregulation of SNP on A23187-induced histamine release from both crude cell populations. In contrast, SNP had no effect on anti-IgE-induced histamine release from either crude or purified basophil preparation in the absence of NAC, and SNP plus NAC inhibited anti-IgE-induced histamine release from both cell preparations. The same results were obtained with crude and purified RPMC preparations under the same conditions. These results show that SNP similarly downregulated exocytosis of basophils and RPMC, and acquired the potent effect in the presence of NAC, indicating that exogenous NO plays a part in the regulation of basophil and mast cell activation.

Keywords:
Basophils, Histamine, Mast cells, N-Acetylcysteine, Sodium nitroprusside
1.
Lemanske RF Jr, Kaliner M: Late-phase IgE-mediated reactions. J Clin Immunol 1988;8:1–13.
2.
Charlesworth EN, Hood AF, Soter NA, Sobotka AK, Norman PS, Lichtenstein LM: Cutaneous late-phase response to allergen. J Clin Invest 1989;83:1519–1526.
3.
Iliopoulos O, Baroody FM, Naclerio RM, Bochner BS, Sobotka AK, Lichtenstein LM: Histamine-containing cells obtained from the nose hours after antigen challenge have functional and phenotypic characteristics of basophils. J Immunol 1992;148:2223–2228.
4.
Naclerio RM, Proud D, Togias AG, Adkinson NF Jr, Meyers DA, Sobotka AK, Plaut M, Norman PS, Lichtenstein LM: Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med 1985;313:65–70.
5.
Koshino T, Arai Y, Miyamoto Y, Sano Y, Takaishi T, Hirai K, Ito K, Morita Y: Mast cell and basophil number in the airway correlate with the bronchial responsiveness of asthmatics. Int Arch Allergy Immunol 1995;107:378–379.
6.
Koshino T, Teshima S, Fukushima N, Takaishi T, Hirai K, Miyamoto Y, Arai Y, Sano Y, Ito K, Morita Y: Identification of basophils by immunohistochemistry in the airways of post-mortem cases of fatal asthma. Clin Exp Allergy 1993;23:919–925.
7.
Guo C-B, Liu MC, Galli SJ, Bochner BS, Sobotka AK, Lichtenstein LM: Identification of IgE-bearing cells in the late-phase response to antigen in the lung as basophils. Am J Respir Cell Mol Biol 1994;10:384–390.
8.
Lander HM, Sehajpal P, Levine DM, Novogrodsky A: Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J Immunol 1993;150:1509–1526.
9.
Sheffler LA, Wink DA, Melillo G, Cox GW: Exogenous nitric oxide regulated IFN-γ plus lipopolysaccharide-induced nitric oxide synthase expression in mouse macrophages. J Immunol 1995;155:886–894.
10.
Van Dervort AL, Yan L, Madara PJ, Cobb JP, Wesley RA, Corriveau CC, Tropea MM, Danner RL: Nitric oxide regulates endotoxin-induced TNF-α production by human neutrophils. J Immunol 1994;152:4102–4109.
11.
Hamid Q, Springall DR, Riveros-Moreno V, Chanez P, Howarth P, Redington A, Bousquet J, Godard P, Holgate S, Polak JM: Induction of nitric oxide synthase in asthma. Lancet 1993;342:1510–1513.
12.
Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ: Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994;343:133–135.
13.
Persson MG, Zetterstrom O, Argrenius V, Ihre E, Gustafsson LE: Single-breath nitric oxide measurements in asthmatic patients and smokers. Lancet 1994;343:146–147.
14.
Masini E, Salvemini D, Pistelli A, Mannaioni PF, Vane JR: Rat mast cells synthesize a nitric oxide like-factor which modulates the release of histamine. Agents Actions 1991;33:61–63.
15.
Mannaioni PF, Masini E, Pistelli A, Salvemini D, Vane JR: Mast cells as a source of superoxide anions and nitric oxide-like factor: Relevance to histamine release. Int J Tissue React 1991;13:271–278.
16.
Masini E, Dibello MG, Pistelli A, Raspanti S, Gambassi F, Mugnai L, Lupini M, Mannaioni PF: Generation of nitric oxide from nitrovasodilators modulates the release of histamine from mast cells. J Physiol Pharmacol 1994;45:41–53.
17.
Rudolph AK, Burrows PD, Wabl MR: Thirteen hybridomas secreting hapten-specific immunoglobulin E from mice with Iga or Igb heavy chain haplotype. Eur J Immunol 1981;11:527–529.
18.
Wells E, Mann J: Phosphorylation of a mast cell protein in response to treatment with anti-allergic compounds: Implications for the mode of action of sodium cromoglycate. Biochem Pharmacol 1983;32:837–842.
19.
Hirai K, Morita Y, Misaki Y, Ohta K, Takaishi T, Suzuki S, Motoyoshi K, Miyamoto T: Modulation of human basophil histamine release by hemopoietic growth factors. J Immunol 1988;141:3958–3964.
20.
Yamaguchi M, Hirai K, Morita Y, Takaishi T, Ohta K, Suzuki S, Motoyoshi K, Kawanami O, Ito K: Hemopoietic growth factors regulate the survival of human basophils in vitro. Int Arch Allergy Immunol 1992;97:322–329.
21.
Siraganian RP: Refinements in automated fluorometric histamine analysis system. J Immunol Methods 1975;7:283–290.
22.
Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, Gruetter CA: Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: Evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981;218:739–749.
23.
Gaston B, Drazen JM, Loscalzo J, Stamler JS: The biology of nitrogen oxides in the airway. Am J Respir Crit Care Med 1994;149:538–551.
24.
Palmer RMJ, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524–526.
25.
Kharitonov SA, O’Connor BJ, Evans DJ, Barnes PJ: Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Am J Respir Crit Care Med 1995;151:1894–1899.
26.
Wright CD, Mulsch A, Busse R, Osswald H: Generation of nitric oxide by human neutrophils. Biochem Biophys Res Commun 1989;160:813–819.
27.
Peachell PT, Undem BJ, Schleimer RP, MacGlashan DW Jr, Lichtenstein LM, Cieslinski LB, Torphy TJ: Preliminary identification and role of phosphodiesterase isozymes in human basophils. J Immunol 1992;148:2503–2510.
28.
Alam R, Grant JA, Lett-Brown MA: Identification of a histamine release inhibitory factor produced by human mononuclear cells in vitro. J Clin Invest 1988;82:2056–2062.
29.
Valle A, Kinet J-P: N-Acetyl-L-cysteine inhibits antigen-mediated Syk, but not Lyn tyrosine kinase activation in mast cells. FEBS Lett 1995;357:41–44.
30.
Bidri M, Becherel PA, Le-Goff L, Pieroni L, Guillosson JJ, Debre P, Arock M: Involvement of cyclic nucleotides in the immunomodulatory effects of nitric oxide on murine mast cells. Biochem Biophys Res Commun 1995;210:507–517.
31.
Kubes P, Kanwar S, Niu X-F, Gaboury JP: Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J 1993;7:1293–1299.
32.
Kanwar S, Wallace JL, Befus D, Kubes P: Nitric oxide synthesis inhibition increases epithelial permeability via mast cell. Am J Physiol 1994;266:G222–G229.
33.
Amir S, English AM: An inhibitor of nitric oxide production, NG-nitro-L-arginine-methyl ester, improves survival in anaphylactic shock. Eur J Pharmacol 1991;203:125–127.
34.
Taylor-Robinson AW, Liew FY, Severin A, Xu D, McSorley SJ, Garside P, Padron J, Phillips RS: Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper Type 2 cells. Eur J Immunol 1994;24:980–984.
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.